Tacrolimus 0.03% w/w Ointment

Tacrolimus 0.03% w/w is a non-steroid topical calcineurin inhibitor for atopic dermatitis when suitable initial topical treatments have not provided enough control or are not appropriate.
Apply a thin layer to affected skin, usually twice daily during a flare, and rub in gently. Wash the hands afterwards unless treating them. Do not cover with an airtight dressing or apply inside the eyes or mouth. Use is intermittent rather than continuous indefinitely.
Tacrolimus inhibits calcineurin-dependent activation of skin T cells, reducing inflammatory cytokine signalling involved in eczema.
Temporary burning, warmth, itching or redness at the application site is common, especially during the first days. Folliculitis, skin infection or cold-sore reactivation can occur.
Limit unnecessary ultraviolet exposure and avoid applying to untreated infected lesions. New persistent skin lumps, swollen glands or a changing lesion needs assessment. Ointment strength affects age suitability: 0.03% is the paediatric strength from age two, while 0.1% is generally for age sixteen and above.
Can reduce eczema inflammation and itching without corticosteroid-related skin thinning.
No. It suppresses a different skin immune pathway and does not cause the same steroid-related skin atrophy.
Inflamed eczema skin can sting or feel warm when treatment begins. This often becomes less noticeable as inflammation settles.
No. Viral or bacterial infection at the treatment site needs assessment before applying an immune-modulating skin medicine.
Some people notice warmth or flushing after drinking alcohol during treatment. Avoiding alcohol prevents that trigger.
Calcineurin inhibitor: a medicine reducing activation of certain immune cells. Atopic dermatitis: an inflammatory eczema disorder. Cytokine: a messenger used by immune cells. Skin atrophy: thinning of the skin.; AR: Tacrolimus 0.03% w/w مرهم; FR: Tacrolimus 0.03% w/w pommade; PT: Tacrolimus 0.03% w/w pomada; ES: Tacrolimus 0.03% w/w pomada; RU: Tacrolimus 0.03% w/w мазь; ID: Tacrolimus 0.03% w/w salep; VI: Tacrolimus 0.03% w/w thuốc mỡ; MS: Tacrolimus 0.03% w/w salap; TL: Tacrolimus 0.03% w/w pamahid; ZH-SG: Tacrolimus 0.03% w/w 软膏
International B2B Enquiry
Send a structured B2B enquiry for Tacrolimus 0.03% w/w Ointment under Skin Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Tacrolimus 0.03% w/w Ointment